AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Apr 29, 2019

3377_rpt_2019-04-29_6310fdfa-19e3-4300-834c-c6ceeee4dbc9.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management

Pursuant to Article 19 of Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (market abuse regulation) and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016, Novozymes hereby publishes the following transactions under ISIN code DK0060336014, Novozymes B shares (ticker symbol NZYM B). This sale has been conducted pursuant to Novo Holdings A/S' previously announced intention to maintain its relative holding of approximately 25.5% of the total common stock which was the level prior to Novozymes' capital reduction of March 29, 2019 (Company announcement No. 1, January 24, 2019).

Name Novo Holdings A/S
Reason for notification
Position/status Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and a
member of the Board of Directors for Novozymes A/S
Initial notification/ Initial notification
amendment

Details of the issuer

Entity Novozymes A/S
LEI code 529900T6WNZXD2R3JW38

Details of the transaction(s)

Description:
Financial instrument Shares
Identification code ISIN DK0060336014
Nature of the transaction Sale of shares
Place(s) of transaction(s),
price(s) and volume(s) Price(s) Volume(s)
302.39 765,000 shares
Aggregated information Number of shares: 765,000
Average price, DKK: 302.39
Transaction value, DKK: 231,328,350.00
Date of the transaction 2019-04-29

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38

April 29, 2019 Company announcement No. 10

Contact information [email protected]

Tobias Cornelius Björklund +45 3077 8682 [email protected]

Carl Ahlgren +45 3077 2783 [email protected]

Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark

Phone: +45 4446 0000

Talk to a Data Expert

Have a question? We'll get back to you promptly.